Select Page

This report studies the global market size of Diabetes Injection Pens in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetes Injection Pens in these regions. This research report categorizes the global Diabetes Injection Pens market by top players/brands, region, type and end user. This report also studies the global Diabetes Injection Pens market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The global Diabetes Injection Pens market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Diabetes Injection Pens market based on company, product type, end user and key regions. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Novo Nordisk A/S Eli Lilly and Company AstraZeneca plc Biocon Ltd. Sanofi S.A. Becton, Dickinson and Company Owen Mumford Ltd. Jiangsu Delfu Co., Ltd. Wockhardt Ltd. Market size by Product Insulin Pens Pen Needles Market size by End User Hospital Pharmacy Retail Pharmacy Online Sales Diabetes Clinics/ Centers Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Diabetes Injection Pens market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025. To understand the structure of Diabetes Injection Pens market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Diabetes Injection Pens companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Diabetes Injection Pens submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Diabetes Injection Pens are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetes Injection Pens market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=90364

Table of Contents:

Table of Contents

1 Study Coverage
1.1 Diabetes Injection Pens Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Diabetes Injection Pens Market Size Growth Rate by Product
1.4.2 Insulin Pens
1.4.3 Pen Needles
1.5 Market by End User
1.5.1 Global Diabetes Injection Pens Market Size Growth Rate by End User
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Sales
1.5.5 Diabetes Clinics/ Centers
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Diabetes Injection Pens Market Size
2.1.1 Global Diabetes Injection Pens Revenue 2013-2025
2.1.2 Global Diabetes Injection Pens Sales 2013-2025
2.2 Diabetes Injection Pens Growth Rate by Regions
2.2.1 Global Diabetes Injection Pens Sales by Regions
2.2.2 Global Diabetes Injection Pens Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Diabetes Injection Pens Sales by Manufacturers
3.1.1 Diabetes Injection Pens Sales by Manufacturers
3.1.2 Diabetes Injection Pens Sales Market Share by Manufacturers
3.1.3 Global Diabetes Injection Pens Market Concentration Ratio (CR5 and HHI)
3.2 Diabetes Injection Pens Revenue by Manufacturers
3.2.1 Diabetes Injection Pens Revenue by Manufacturers (2013-2018)
3.2.2 Diabetes Injection Pens Revenue Share by Manufacturers (2013-2018)
3.3 Diabetes Injection Pens Price by Manufacturers
3.4 Diabetes Injection Pens Manufacturing Base Distribution, Product Types
3.4.1 Diabetes Injection Pens Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diabetes Injection Pens Product Type
3.4.3 Date of International Manufacturers Enter into Diabetes Injection Pens Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Diabetes Injection Pens Sales by Product
4.2 Global Diabetes Injection Pens Revenue by Product
4.3 Diabetes Injection Pens Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Diabetes Injection Pens Breakdown Data by End User

6 North America
6.1 North America Diabetes Injection Pens by Countries
6.1.1 North America Diabetes Injection Pens Sales by Countries
6.1.2 North America Diabetes Injection Pens Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Diabetes Injection Pens by Product
6.3 North America Diabetes Injection Pens by End User

7 Europe
7.1 Europe Diabetes Injection Pens by Countries
7.1.1 Europe Diabetes Injection Pens Sales by Countries
7.1.2 Europe Diabetes Injection Pens Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Diabetes Injection Pens by Product
7.3 Europe Diabetes Injection Pens by End User

8 Asia Pacific
8.1 Asia Pacific Diabetes Injection Pens by Countries
8.1.1 Asia Pacific Diabetes Injection Pens Sales by Countries
8.1.2 Asia Pacific Diabetes Injection Pens Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Diabetes Injection Pens by Product
8.3 Asia Pacific Diabetes Injection Pens by End User

9 Central & South America
9.1 Central & South America Diabetes Injection Pens by Countries
9.1.1 Central & South America Diabetes Injection Pens Sales by Countries
9.1.2 Central & South America Diabetes Injection Pens Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Diabetes Injection Pens by Product
9.3 Central & South America Diabetes Injection Pens by End User

10 Middle East and Africa
10.1 Middle East and Africa Diabetes Injection Pens by Countries
10.1.1 Middle East and Africa Diabetes Injection Pens Sales by Countries
10.1.2 Middle East and Africa Diabetes Injection Pens Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Diabetes Injection Pens by Product
10.3 Middle East and Africa Diabetes Injection Pens by End User

11 Company Profiles
11.1 Novo Nordisk A/S
11.1.1 Novo Nordisk A/S Company Details
11.1.2 Company Business Overview
11.1.3 Novo Nordisk A/S Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Novo Nordisk A/S Diabetes Injection Pens Products Offered
11.1.5 Novo Nordisk A/S Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Company Business Overview
11.2.3 Eli Lilly and Company Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Eli Lilly and Company Diabetes Injection Pens Products Offered
11.2.5 Eli Lilly and Company Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Details
11.3.2 Company Business Overview
11.3.AstraZeneca plc Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.3.4 AstraZeneca plc Diabetes Injection Pens Products Offered
11.3.5 AstraZeneca plc Recent Development
11.4 Biocon Ltd.
11.4.1 Biocon Ltd. Company Details
11.4.2 Company Business Overview
11.4.3 Biocon Ltd. Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Biocon Ltd. Diabetes Injection Pens Products Offered
11.4.5 Biocon Ltd. Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Company Business Overview
11.5.3 Sanofi S.A. Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Sanofi S.A. Diabetes Injection Pens Products Offered
11.5.5 Sanofi S.A. Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Company Business Overview
11.6.3 Becton, Dickinson and Company Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Becton, Dickinson and Company Diabetes Injection Pens Products Offered
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Owen Mumford Ltd.
11.7.1 Owen Mumford Ltd. Company Details
11.7.2 Company Business Overview
11.7.3 Owen Mumford Ltd. Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Owen Mumford Ltd. Diabetes Injection Pens Products Offered
11.7.5 Owen Mumford Ltd. Recent Development
11.8 Jiangsu Delfu Co., Ltd.
11.8.1 Jiangsu Delfu Co., Ltd. Company Details
11.8.2 Company Business Overview
11.8.3 Jiangsu Delfu Co., Ltd. Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Jiangsu Delfu Co., Ltd. Diabetes Injection Pens Products Offered
11.8.5 Jiangsu Delfu Co., Ltd. Recent Development
11.9 Wockhardt Ltd.
11.9.1 Wockhardt Ltd. Company Details
11.9.2 Company Business Overview
11.9.3 Wockhardt Ltd. Diabetes Injection Pens Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Wockhardt Ltd. Diabetes Injection Pens Products Offered
11.9.5 Wockhardt Ltd. Recent Development

12 Future Forecast
12.1 Diabetes Injection Pens Market Forecast by Regions
12.1.1 Global Diabetes Injection Pens Sales Forecast by Regions 2018-2025
12.1.2 Global Diabetes Injection Pens Revenue Forecast by Regions 2018-2025
12.2 Diabetes Injection Pens Market Forecast by Product
12.2.1 Global Diabetes Injection Pens Sales Forecast by Product 2018-2025
12.2.2 Global Diabetes Injection Pens Revenue Forecast by Product 2018-2025
12.3 Diabetes Injection Pens Market Forecast by End User
12.4 North America Diabetes Injection Pens Forecast
12.5 Europe Diabetes Injection Pens Forecast
12.6 Asia Pacific Diabetes Injection Pens Forecast
12.7 Central & South America Diabetes Injection Pens Forecast
12.8 Middle East and Africa Diabetes Injection Pens Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diabetes Injection Pens Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Buy this report online:

https://www.marketdensity.com/global-diabetes-injection-pens-market-insights-forecast